A group of Democratic senators are calling on Health and Human Services Secretary Robert F. Kennedy Jr. to keep a proposed ...

The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

Under Friday’s final ruling anti-obesity medications for weight-loss will remain ineligible for Medicare coverage.

The Centers for Medicare and Medicaid Services said late Friday that it would not cover medications such as Wegovy that are ...

CMS ends Biden-era proposal to expand Medicare coverage of anti-obesity drugs. Seniors continue paying out of pocket for Wegovy and Zepbound ...

Democrat senators are begging Health and Human Services Secretary (HHS) Robert F. Kennedy Jr. to keep a proposed Biden-era rule pertaining to obesity drugs. In November, the […] ...

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the ...

The Biden administration sought to sidestep this obstacle by issuing a rule in November reinterpreting existing statutes to allow for Medicare Part D to cover anti-obesity drugs. But earlier this ...

President Donald Trump and Health Secretary Robert F. Kennedy Jr. have pledged to “make America healthy again.” If Congress ...

The previous administration attempted to have Medicare Part D and Medicaid cover anti-obesity drugs under the Contract Year 2026 MA and Part D rule, which would have substantially increased access ...

The Centers for Medicare and Medicaid ... frequently touted anti-obesity drugs on his television show and on social media. But expanding coverage would have been expensive, and the Trump administr ...